Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults.
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
Alemtuzumab for the Treatment of Multiple Sclerosis
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis
Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR.
Receptos reports third quarter 2013 financial results
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath.
Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Necrotizing skin lesion and radial nerve palsy in a patient treated with glatiramer acetate.
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
Determination and characterization of a cannabinoid receptor in rat brain.
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
Intermittent self-catheterisation in MS.
Biogen Idec completes purchase of full rights and control of Tysabri®
EMD Serono
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Receptos to deliver scientific presentations about RPC1063 at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Genzyme presents second Phase III study of once-daily oral AUBAGIO® (teriflunomide) confirming significant impact on disability
Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.

Pages